Stay updated on Botensilimab in Metastatic Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Botensilimab in Metastatic Pancreatic Cancer Clinical Trial page.

Latest updates to the Botensilimab in Metastatic Pancreatic Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedA new revision entry v3.6.3 has been added to the study's history, superseding the previous v3.6.2 entry.SummaryDifference0.1%

- Check17 days agoChange DetectedThe history section now shows a newer software revision (v3.6.2) replacing the older v3.6.0, indicating a background deployment that updates how history is displayed.SummaryDifference0.1%

- Check31 days agoChange DetectedThe record now shows the study is Completed and no longer looking for participants, with the Recruitment Status and Study Status sections updated accordingly to reflect the end of recruitment.SummaryDifference2%

- Check38 days agoChange DetectedA new revision entry Revision: v3.5.5 has been added to the history, replacing the prior Revision: v3.5.4. This indicates an update to the page's version history.SummaryDifference0.1%

- Check60 days agoChange DetectedThe record history now shows a new revision, v3.5.4, as the latest entry, replacing the prior v3.5.3. This reflects a minor update to the page's version history rather than content changes.SummaryDifference0.1%

- Check82 days agoChange DetectedA minor update to the ClinicalTrials.gov page’s revision/version indicator is shown (v3.5.2 → v3.5.3). This reflects a platform or release change rather than a change to the underlying trial record.SummaryDifference0.1%

Stay in the know with updates to Botensilimab in Metastatic Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Botensilimab in Metastatic Pancreatic Cancer Clinical Trial page.